Biotech

Startups

Biotech Startups Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Biotech

Top news of the week: 01.11.2022.

#funding
#future
#mobiletechnology
#entrepreneurship
#growth
#startups
#innovation
#lifesciences

@ldtimmerman shared
On Oct 26, 2022
Fun fact: In 2017, @dawallach gave me the opening theme music for The Long Run podcast. I loved it then, and still do. Cool to see him moving up in the biotech VC world. See @statnews https://t.co/4c9hTgjBiY
Open
Biotech’s newest odd couple: A pharma insider and a music maven launch a health care VC

Biotech’s newest odd couple: A pharma insider and a music maven launch a health care VC

How a pharma insider and a onetime music maven found common ground in health care investment.

@500GlobalVC shared
On Oct 31, 2022
@vishalharnal has had more than a ringside seat to Southeast Asia’s transformation into a hotbed of innovation and tells us what’s in store for the future. Listen To Full Interview: https://t.co/ogO7MUCU1e #funding #startups #entrepreneurship #growth #mobiletechnology #future https://t.co/vm6g5c1Ewd
Open
Birthing Southeast Asia’s New Tech Giants

Birthing Southeast Asia’s New Tech Giants

500 Global made its first investment in Southeast Asia 10 years ago. Managing Partner Vishal Harnal tells us what’s in store for the future.

@MALifeSciences shared
On Oct 31, 2022
RT @NucleateHQ: Nucleate Boston is excited to partner with the Massachusetts Life Science Center @MALifeSciences to support the formation of early-stage biotech ventures. https://t.co/2JzlJLYPq6 https://t.co/rfoWzzGspu
Open
Nucleate Boston partners with the Massachusetts Life Science Center to support the formation of early-stage biotech ventures

Nucleate Boston partners with the Massachusetts Life Science Center to support the formation of early-stage biotech ventures

Massachusetts Life Sciences Center extends grant to Nucleate Boston’s Activator Program to support promising early stage technology…

@MALifeSciences shared
On Oct 28, 2022
RT @MansfieldBioinc: Grateful to @MALifeSciences for making last week's Grand Opening possible. Together we grow Boston-Providence #lifesciences #innovation corridor. See the press-release, photos, and a video replay below. https://t.co/67mjObsWzK https://t.co/sz8fZgfmGl https://t.co/NTgUWPfk7I
Open
Mansfield Bio-Incubator Unveils Expanded Lab Campus

Mansfield Bio-Incubator Unveils Expanded Lab Campus

With 26,000 total square feet of lab space, the expansion cements the non-profit incubator as one of the largest collaborative life sciences spaces in Massachusetts’s booming biotech ...

@ldtimmerman shared
On Oct 26, 2022
Biotech executives call for action on reproductive health rights. https://t.co/HKqHKuQT9d
Open
Biotech Executives Call for Action on Reproductive Health Rights

Biotech Executives Call for Action on Reproductive Health Rights

Dear Friends and Biopharma colleagues,  The rapidly approaching midterm elections carry the potential to dramatically reshape the political landscape in myriad ways. The importance of the ...

@adamfeuerstein shared
On Oct 27, 2022
RT @owermohle: My Readout Loud ✨debut ✨ discussing the midterm elections and their implications for public health and science. Fun to join @ADeAngelis_bio @adamfeuerstein @damiangarde https://t.co/IhZazqC5pf
Open
Listen: Anti-science at the polls, a biotech odd couple, & the stakes of the midterms

Listen: Anti-science at the polls, a biotech odd couple, & the stakes of the midterms

Can Covid denialism get you elected? How is the music business like biotech investing? And what's at stake for science in the midterms? All that and more on the latest episode of "The ...

@BentheFidler shared
On Oct 27, 2022
An unusual alliance opens a gene and cell therapy hub outside Boston https://t.co/joccFhAeZN by @gwendolynawu @landmarkbio
Open
An unusual alliance opens a gene and cell therapy hub outside Boston

An unusual alliance opens a gene and cell therapy hub outside Boston

Landmark Bio, armed with $75 million and a wide range of backers, is the latest company to emerge with plans to open a “bottleneck” slowing development of the complex medicines.

@GENbio shared
On Oct 31, 2022
RT @AlexWestchester: 31October: What does Form Bio, newly spun out from @geochurch's @itiscolossal, consider its 'sweet spot' for its synthetic biology-focused software platform? My latest for GEN Edge, premium content from @GENbio: https://t.co/xLu1PRRyJl
Open
Form (Bio) Follows Function: Software Platform Targets Synbio

Form (Bio) Follows Function: Software Platform Targets Synbio

Form Bio, a spinout of George Church, PhD co-founded Colossal Biosciences, has developed a platform for synthetic biology researchers.

Read more:
weekly 01.11.2022
View archives
Back to home

Subscribe to Biotech - Startups.

Avoid an information overload and get the most trusted industry news hand-picked by the top Experts. Sign up for the weekly Biotech - Startups.
Privacy Policy

Sign up for the weekly Biotech - Startups newsletter

Never again miss anything or anyone that matter in Biotech

Sign up and receive the Biotech - Startups weekly email newsletter directly to your inbox. Make more informed business decisions based on insight for the most trusted industry experts, faster.
Privacy Policy